These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14622526)

  • 1. [Atheroma plaque stabilization: a new concept based on the dynamic biology of atherosclerosis].
    Páramo JA; Orbe J; Rodríguez JA
    Med Clin (Barc); 2003 Nov; 121(15):583-7. PubMed ID: 14622526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is regression of atherosclerotic plaque possible?].
    Páramo JA; Civeira F
    Clin Investig Arterioscler; 2017; 29(1):46-50. PubMed ID: 27692635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis imaging: intravascular ultrasound.
    Tuzcu EM; Schoenhagen P
    Drugs; 2004; 64 Suppl 2():1-7. PubMed ID: 15765887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid lowering therapy and stabilization of atherosclerotic plaques.
    Krone W; Müller-Wieland D
    Thromb Haemost; 1999 Sep; 82 Suppl 1():60-1. PubMed ID: 10695487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents that stabilise atherosclerotic plaque.
    Chiong JR; Miller AB
    Expert Opin Investig Drugs; 2003 Oct; 12(10):1681-92. PubMed ID: 14519087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What have we learned about the biology of atherosclerosis? The role of inflammation.
    Libby P
    Am J Cardiol; 2001 Oct; 88(7B):3J-6J. PubMed ID: 11595192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulnerable plaque: pathobiology and clinical implications.
    Kullo IJ; Edwards WD; Schwartz RS
    Ann Intern Med; 1998 Dec; 129(12):1050-60. PubMed ID: 9867761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of atherosclerotic plaque during lipid lowering.
    Müller-Wieland D; Kotzka J; Krone W
    Curr Opin Lipidol; 1997 Dec; 8(6):348-53. PubMed ID: 9412775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of apoptosis in atherosclerosis and its therapeutic implications.
    Stoneman VE; Bennett MR
    Clin Sci (Lond); 2004 Oct; 107(4):343-54. PubMed ID: 15230690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new paradigm for plaque stabilization.
    Ambrose JA; Martinez EE
    Circulation; 2002 Apr; 105(16):2000-4. PubMed ID: 11997290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary rationale for non-invasive imaging of adverse coronary plaque features to identify the vulnerable patient: a Position Paper from the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology and the European Association of Cardiovascular Imaging.
    Dweck MR; Maurovich-Horvat P; Leiner T; Cosyns B; Fayad ZA; Gijsen FJH; Van der Heiden K; Kooi ME; Maehara A; Muller JE; Newby DE; Narula J; Pontone G; Regar E; Serruys PW; van der Steen AFW; Stone PH; Waltenberger JL; Yuan C; Evans PC; Lutgens E; Wentzel JJ; Bäck M
    Eur Heart J Cardiovasc Imaging; 2020 Oct; 21(11):1177-1183. PubMed ID: 32887997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pathogenesis of the evolution of the atheroma plaque].
    Ferreira Montero IJ; Ferreira Aguar AI; Casasnovas Lenguas JA
    Rev Esp Cardiol; 1995; 48 Suppl 5():13-22. PubMed ID: 7494935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology.
    Ylä-Herttuala S; Bentzon JF; Daemen M; Falk E; Garcia-Garcia HM; Herrmann J; Hoefer I; Jukema JW; Krams R; Kwak BR; Marx N; Naruszewicz M; Newby A; Pasterkamp G; Serruys PW; Waltenberger J; Weber C; Tokgözoglu L
    Thromb Haemost; 2011 Jul; 106(1):1-19. PubMed ID: 21670845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular palpography for high-risk vulnerable plaque assessment.
    Schaar JA; de Korte CL; Mastik F; Baldewsing R; Regar E; de Feyter P; Slager CJ; van der Steen AF; Serruys PW
    Herz; 2003 Sep; 28(6):488-95. PubMed ID: 14569389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vulnerable plaque: the real villain in acute coronary syndromes.
    Liang M; Puri A; Devlin G
    Open Cardiovasc Med J; 2011; 5():123-9. PubMed ID: 21673834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regression of atherosclerotic plaques during treatment with statins].
    Kovárník T; Aschermann M
    Cas Lek Cesk; 2004; 143(10):669-74; discussion 674-5. PubMed ID: 15584615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to achieve coronary arterial plaque stabilization.
    Rabbani R; Topol EJ
    Cardiovasc Res; 1999 Feb; 41(2):402-17. PubMed ID: 10341840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dyslipidemia, atherosclerosis, and vulnerable plaques: the effect of atorvastatin on atherosclerosis and plaque structure].
    Tokgözoğlu L
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():11-6. PubMed ID: 19404045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of arterial atheroma.
    Willeit J; Kiechl S
    Cerebrovasc Dis; 2000; 10 Suppl 5():1-8. PubMed ID: 11096178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms modifying atherosclerotic disease - from lipids to vascular biology.
    Weissberg P
    Atherosclerosis; 1999 Sep; 147 Suppl 1():S3-10. PubMed ID: 10575056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.